Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial.

Saved in:
Bibliographic Details
Title: Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial.
Authors: Meattini I; Department of Experimental and Clinical Biomedical Sciences 'M. Serio', University of Florence, Florence, Italy; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy. Electronic address: icro.meattini@unifi.it., De Santis MC; Radiation Oncology, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Visani L; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Scorsetti M; Department of Radiotherapy and Radiosurgery, Istituto Clinico Humanitas - Humanitas Cancer Center, Milan, Italy., Fozza A; Radiation Oncology Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Meduri B; Department of Radiation Oncology, University Hospital of Modena, Modena, Italy., De Rose F; Department of Radiation Oncology, Santa Chiara Hospital, Trento, Italy., Bonzano E; Department of Radiation Oncology, IRCCS San Matteo Polyclinic Foundation, Pavia, Italy., Prisco A; Department of Radiation Oncology, 'Santa Maria della Misericordia' University Hospital, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy., Masiello V; UOC di Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy., La Rocca E; Radiation Oncology, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Spoto R; Department of Radiotherapy and Radiosurgery, Istituto Clinico Humanitas - Humanitas Cancer Center, Milan, Italy., Becherini C; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Blandino G; Radiation Oncology Department, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Moscetti L; Oncology and Hematology Department, Azienda Ospedaliero-Universitaria di Modena, Modena, Italy., Colciago RR; Radiation Oncology, Fondazione IRCCS Istituto Nazionale Tumori di Milano, Milan, Italy., Audisio RA; Department of Surgery, Institute of Clinical Sciences, Sahlgrenska University Hospital, Göteborg, Sweden., Brain E; Paris Sciences and Lettres University, Paris, France; Institut Curie, Hopital René Huguenin, Saint-Cloud, France., Caini S; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy., Hamaker M; Department of Geriatric Medicine, Diakonessenhuis Utrecht, Utrecht, Netherlands., Kaidar-Person O; Breast Cancer Radiation Therapy Unit, Sheba Medical Center, Ramat Gan, Israel; The Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel; GROW-School for Oncology and Reproduction (Maastro), Maastricht University, Maastricht, Netherlands., Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genova, Italy; Department of Medical Oncology, UOC Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy., Marrazzo L; Department of Experimental and Clinical Biomedical Sciences 'M. Serio', University of Florence, Florence, Italy; Medical Physics Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy., Saieva C; Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy., Spanic T; Europa Donna, European Breast Cancer Coalition, Milan, Italy; Europa Donna Slovenia, Ljubljana, Slovenia., Strnad V; Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany., Wheelwright S; Sussex Health Outcomes Research & Education in Cancer (SHORE-C), Brighton & Sussex Medical School, University of Sussex, Brighton, East Sussex, UK., Poortmans PMP; Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium., Livi L; Department of Experimental and Clinical Biomedical Sciences 'M. Serio', University of Florence, Florence, Italy; Radiation Oncology Unit, Oncology Department, Azienda Ospedaliero Universitaria Careggi, Florence, Italy.
Corporate Authors: EUROPA Trial Investigators
Source: The Lancet. Oncology [Lancet Oncol] 2025 Jan; Vol. 26 (1), pp. 37-50. Date of Electronic Publication: 2024 Dec 12.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study; Comparative Study; Equivalence Trial
Journal Info: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1474-5488
DOI:10.1016/S1470-2045(24)00661-2